SPARCnm136 mutations (i.e. Df(3R)nm136 in combination with His2AvT:Avic\GFP-S65T) do not display embryonic VNC defects or embryonic lethality when homozygous or heterozygous with Df(3R)BSC524. Instead, these animals die during larval stages.
Unlike wild type larvae, many SPARCnm136 mutants (i.e. Df(3R)nm136 in combination with His2AvT:Avic\GFP-S65T) crawl away from the yeast/agar and become stationary on the plate wall as 1st instars. SPARCnm136/Df(3R)BSC524 animals that survive for 72-96 hr are smaller with reduced fat bodies compared to wild type - they do not pupate and often develop necrotic bodies and have a deformed proventriculus. Processing of food appears normal in the mutants - they stop feeding prior to the emergence of proventricular defects.
MARCM-generated fat body clones mutant for SPARCnm136 (i.e. Df(3R)nm136 in combination with His2AvT:Avic\GFP-S65T) results in adipocyte cell rounding, membrane blebbing and cortical actin reorganisation.
SPARCMI00329/SPARCnm136 fat body from 3rd instar larvae shows a disruption of tissue morphology - adipocytes are rounded and membranes bleb. Whereas wild type adipocytes are polygonal, these mutant adipocytes are spherical with an increased number of surface pits.
BM-40-SPARCnm136 mutant embryos do not display normal anterior Malpighian tubule migration, and the anterior pair of tubules project posteriorly in these animals.
SPARCnm136 mutant embryos (co-expressing His2AvT:Avic\GFP-S65T to rescue defects due to disruption of His2Av) display holes in the ventral cuticles, often accompanied by a loss of anterior cuticle and head involution defects. Tracheal defects are also evident, including constricted or broken dorsal-longitudinal tracheal trunks.
SPARCnm136 is rescued by SPARCUAS.cMa/Scer\GAL4Cg.PA
Scer\GAL4Cg.PA-mediated expression of BM-40-SPARCScer\UAS.cMa rescues SPARCnm136 mutants to adulthood.
BM-40-SPARCCH322-97I07 rescues the larval lethality associated with SPARCnm136 mutants (i.e. Df(3R)nm136 in combination with His2AvT:Avic\GFP-S65T).
Expression of SPARCScer\UAS.cMa in the haemocytes under the control of Scer\GAL4gcm-rA87.P or Scer\GAL4srp.Hemo fails to rescue embryonic lethality of SPARCnm136 embryos (co-expressing His2AvT:Avic\GFP-S65T to rescue defects due to disruption of His2Av). Ventral cuticle morphology is restored and tracheal defects are suppressed in these embryos.
Expression of SPARCScer\UAS.cMa in neural tissues under the control of Scer\GAL4sca-109-68 fails to rescue the mutant phenotype of SPARCnm136 embryos (co-expressing His2AvT:Avic\GFP-S65T to rescue defects due to disruption of His2Av).
Separable from: neurnm136.
The nervous system defects and embryonic lethality observed in BM-40-SPARCnm136 embryos are not due to absence of SPARC, but rather due to neurnm136, a second-site mutation on the chromosome.
FlyBase curator comment: The lethality and ventral nerve cord phenotypes associated with SPARCnm136 in this paper have been removed as a subsequent paper (FBrf0227915) by the same group shows that these effects are caused by a second-site mutation in neur.